Reaxa showcases Ni EnCat technology

By Phil Taylor

- Last updated on GMT

Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.

Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.

Related news

Related products

show more

A Culture of Innovation as a Differentiation

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Follow us

Products

View more

Webinars